Fellowship · New Haven, CT
Sponsored by Yale-New Haven Hospital
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
The New England journal of medicine · 2022 · 2,297 citations · Silvio Inzucchi
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America.
Journal of cardiac failure · 2025 · 364 citations · Tariq Ahmad
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
The New England journal of medicine · 2021 · 1,462 citations · Jeffrey Testani
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.
The New England journal of medicine · 2025 · 319 citations · Silvio Inzucchi
Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America.
Journal of cardiac failure · 2023 · 581 citations · Tariq Ahmad
The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023 · 511 citations · Eugene DePasquale
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials.
Lancet (London, England) · 2022 · 790 citations · Silvio Inzucchi
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
The New England journal of medicine · 2021 · 933 citations · Silvio Inzucchi